本页面由Tiger Trade Technology Pte. Ltd.提供服务

Vera Therapeutics, Inc.

27.72
-2.1600-7.23%
盘后:27.720.00000.00%19:59 EDT
成交量:140.56万
成交额:3,960.10万
市值:19.88亿
市盈率:-4.70
高:29.49
开:29.11
低:27.64
收:29.88
52周最高:56.05
52周最低:23.05
股本:7,171.39万
流通股本:5,239.41万
量比:0.63
换手率:2.68%
股息:- -
股息率:- -
每股收益(TTM):-5.8984
每股收益(LYR):-4.6644
净资产收益率:-91.75%
总资产收益率:-46.76%
市净率:4.88
市盈率(LYR):-5.94

数据加载中...

2024/05/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/04/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/26

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/20

重要事件披露

Form 8-K - Current report
2024/02/20

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/05

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/30

重要事件披露

Form 8-K - Current report
2024/01/29

重要事件披露

Form 8-K - Current report
2024/01/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/25

重要事件披露

Form 8-K - Current report